AllianceBernstein’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-144,045
| Closed | -$14M | – | 3176 |
|
|
2019
Q3 | $14M | Sell |
144,045
-4,855
| -3% | -$486K | 0.01% | 908 |
|
|
2019
Q2 | $15.2M | Buy |
148,900
+31,191
| +26% | +$3.37M | 0.01% | 897 |
|
|
2019
Q1 | $13.4M | Buy |
117,709
+21,649
| +23% | +$1.59M | 0.01% | 938 |
|
|
2018
Q4 | $3.76M | Sell |
96,060
-435,124
| -82% | -$18.9M | ﹤0.01% | 1455 |
|
|
2018
Q3 | $29M | Buy |
531,184
+147,158
| +38% | +$10.1M | 0.02% | 679 |
|
|
2018
Q2 | $31.8M | Buy |
384,026
+316,523
| +469% | +$24.4M | 0.02% | 651 |
|
|
2018
Q1 | $4.5M | Buy |
67,503
+893
| +1% | +$51.6K | ﹤0.01% | 1275 |
|
|
2017
Q4 | $3.42M | Sell |
66,610
-200
| -0.3% | -$14.4K | ﹤0.01% | 1468 |
|
|
2017
Q3 | $5.96M | Buy |
66,810
+6,310
| +10% | +$479K | ﹤0.01% | 1129 |
|
|
2017
Q2 | $3.61M | Buy |
60,500
+9,400
| +18% | +$525K | ﹤0.01% | 1413 |
|
|
2017
Q1 | $2.73M | Hold |
51,100
| – | – | ﹤0.01% | 1587 |
|
|
2016
Q4 | $2.55M | Hold |
51,100
| – | – | ﹤0.01% | 1661 |
|
|
2016
Q3 | $3.07M | Sell |
51,100
-5,800
| -10% | -$334K | ﹤0.01% | 1454 |
|
|
2016
Q2 | $2.91M | Buy |
56,900
+20,200
| +55% | +$863K | ﹤0.01% | 1400 |
|
|
2016
Q1 | $1.08M | Hold |
36,700
| – | – | ﹤0.01% | 2047 |
|
|
2015
Q4 | $1.66M | Sell |
36,700
-2,440
| -6% | -$128K | ﹤0.01% | 1772 |
|
|
2015
Q3 | $1.63M | Buy |
39,140
+23,230
| +146% | +$1.21M | ﹤0.01% | 1815 |
|
|
2015
Q2 | $959K | Buy |
15,910
+4,400
| +38% | +$291K | ﹤0.01% | 2308 |
|
|
2015
Q1 | $892K | Buy |
+11,510
| New | +$663K | ﹤0.01% | 2246 |
|
AllianceBernstein's ONCE Position: Q4 2019 in Review
AllianceBernstein sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 144,045 shares — an estimated $14M sold.
AllianceBernstein first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $31.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- AllianceBernstein reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- AllianceBernstein sold 144,045 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $14M.
- AllianceBernstein first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- AllianceBernstein's Spark Therapeutics, Inc. Common Stock position peaked at $31.8M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.